A biomarker test to measure progression for Parkinson's Disease is available in the US before 2029
Gesundheit & MedizinOne-Off2JManifold MarketsKein KYCVerifizierte AuflösungsdatenOrdentlich kalibriertAktuelle Community-PrognoseJa 71.7%
Prognostiker
6
Fragetyp
binary
Methodik
Play-money forecasting platform
Quellentyp
Prognose
Marktdaten
Aktualisiert vor 16 Stunden
Veraltet25. Apr. 23, 16:13 UTC2. Jan. 29, 06:59 UTC
Trends
Regeln
There will be a test of a biomarker which meaningfully correlates with parkinson's progression for at least a signficant subset (>10% of those diagnosed clinically) of people with Parkinson's disease in the US before 2029
- examples: Patient has classic non-genetic PD from a clinical diagnosis based on symptoms (rigidity, etc.).
- There will be a test which they can take which shows the severity of the disease, and which when given repeatedly can be used to measure how much or less the disease has progressed
